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Masini: Foreword

Foreword
The Annals of Health Law and Life Sciences Editorial Staff is proud to
present our Winter 2020 Issue. Each year, our Editorial Board seeks out
articles covering important and contemporary topics within the health law
and life sciences law community. The health care and life sciences matters
addressed in the Winter 2020 Issue particularly furthers the Annals tradition
of covering a broad range of current and intriguing topics. These selected
pieces contribute to the continued recognition of Annals of Health Law and
Life Sciences as one of the country's preeminent health and life sciences law
and policy journals.
The first article, authored by George Horvath, discusses a new way the
FDA can address physicians' off-label prescribing practices. Horvath
examines and compares the approved uses of drugs and the off-label drug
uses. Horvath then speaks to the FDA's traditional approach to addressing
the risks of off-label uses, and critiques whether regulation of manufacturers'
off-label promotion is the proper approach. Horvath reviews scholars'
proposals that have been put forward to address the risks associated with offlabel drug use. Horvath concludes by providing his own proposal that
involves a modification of drug labels that provides physicians with
information about how well supported, or unsupported, their off-label
prescriptions are.
The second article, authored by Craig Konnoth, compares the micro- and
macro-level regulation developed in the 2 1 s"Century Cures Act to address
electronic health data. Konnoth first explains the history of health data
regulation and how the 21" Century Cures Act has altered how health
information is structured by providers and health care entities. Konnoth
assesses the micro-level of regulation of electronic health records through the
creation of a voluntary certification program to incentivize. He then
examines the macro-level regulation the Cures Act promotes the national
health information network on which electronic health records are
transmitted. Konnoth posits additional incentives for the voluntary program
and network to ensure successful implementation of electronic health data
regulation.
The third article, authored by Alexandra Foulkes, Jessica Roberts, Paul
Appelbaum, Wendy Chung, Ellen Wright Clayton, Barbara Evans and Gary
Marchant, exhibits a fifty-state survey assessing whether clinical laboratories
are "health care providers" for the purposes of medical malpractice. The
authors strive to address which body of law states apply to clinical genetic
laboratories when facing legal liability. The authors find that six states
expressly include laboratories or laboratory personnel in their statutory
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definition of health care provider, fifteen states have judicial opinions that
treat laboratories as health care providers, and four states have caselaw
concluding that laboratories are not health care providers. However, twentyfive states have yet to decide this matter. The authors conclude that the
legislatures in these states should provide clarity regarding the potential
medical malpractice liability of clinical genetics laboratories.
The fourth article, authored by Katherine Drabiak, provides insight into
the balance between state's police power of removing non-medical
exemptions to vaccinations and public health policies. Drabiak explores the
role of non-medical exemptions, reasons for parental vaccine hesitancy, and
nuances involved in parental decision-making.
Drabiak analyzes
observations and applications of the Supreme Court of the United States'
decisions and dicta in Jacobson v. Massachusetts and Prince v.
Massachusetts. Drabiak exposes how current legislation that removes nonmedical exemptions to vaccinations may exceed the permissible scope of the
state's police power based on Constitutional and jurisprudential limits by
clarifying the development of law in the areas of substantive due process,
informed consent, a child's right to an education, and parental decisionmaking. Drabiak completes the analysis of vaccine law with a discussion of
public health ethics and policy solutions that prioritize accountability,
transparency, and trust.
The fifth article, authored by Jackson Williams, explores the question as
to whether states shall implement reference-based pricing for health care
services or products to contain health care costs. Williams begins by
categorizing current reference-based pricing techniques and discusses the
negotiating or leverage dynamics and practical and legal implications of
each. Williams explores referenced-based pricing policy implementation in
states such as California, Montana, and North Carolina. Williams concludes
that further experimentation of reference-based pricing policies is warranted.
On behalf of the entire Annals of Health Law and Life Sciences Editorial
Staff, I would like to thank George Horvath, Craig Konnoth, Alexandra
Foulkes, Jessica Roberts, Paul Appelbaum, Wendy Chung, Ellen Wright
Clayton, Barbara Evans, Gary Marchant, Katherine Drabiak, and Jackson
Williams for contributing their extraordinary talent and knowledge to this
outstanding issue. This issue is the manifestation of the authors' scholarship
and passion, as well as their exceptional collaboration and professionalism.
The Editorial Board and I would like to thank every member of
the Annals team for their enthusiasm, commitment, and diligence throughout
the editing process. I would also like to express my sincerest gratitude to my
colleagues on the Executive Board: Christina Perez-Tineo, Nicolette Taber,
Alesandra Hlaing, Raquel Boton, Hannah Lehmann, and Jacalyn Smith.
Additionally, I would like to acknowledge the outstanding efforts of our
Senior Editors: Haley Comella, Jan Michael Dervish, Elizabeth Heredia, and
Rachel Kemel. Finally, we would like to thank the amazing faculty at the
Beazley Institute for Health Law and Policy for their continued support of
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our endeavors. The success of this issue would not have been possible
without the hard work and dedication of everyone involved.
It is with great pride that we present the Winter 2020 Issue of Annals of
Health Law andLife Sciences.
Sincerely,
Isabella Masini
Editor-in-Chief
Annals ofHealth Law and Life Sciences
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